Real-World Experience in Toxicity with Bevacizumab in Indian Cancer Patients.

Patil, Pratik P; Rangaraju, Ranga R; Abbas, Waseem; Garg, Sunny

Patil, Pratik P; Rangaraju, Ranga R; Abbas, Waseem; Garg, Sunny.

Afiliação

Patil PP; Department of Medical Oncology, Max Super Specilaity Hospital, New Delhi, India.
Rangaraju RR; Department of Medical Oncology, Max Super Specilaity Hospital, New Delhi, India.
Abbas W; Department of Medical Oncology, Max Super Specilaity Hospital, New Delhi, India.
Garg S; Department of Medical Oncology, Max Super Specilaity Hospital, New Delhi, India.

South Asian J Cancer ; 10(2): 131-134, 2021 Apr.

Article em En | MEDLINE | ID: mdl-34568227

Palavras-chave

bevacizumab; monoclonal antibody; vascular endothelial growth factor α

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Risk_factors_studies Idioma: En Revista: South Asian J Cancer Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Índia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google